Anika Therapeutics/ US0352551081 /
| 1/15/2021 9:59:58 PM | Chg. -1.91 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 39.08USD | -4.66% | 2,639 Turnover: 104,105.03 |
-Bid Size: - | -Ask Size: - | 41.17 | 39.08 |
GlobeNewswire
10/22/2020
Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4...
GlobeNewswire
10/21/2020
Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacem...
GlobeNewswire
9/8/2020
Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors
GlobeNewswire
9/1/2020
Oculis establishes presence in U.S. and appoints Sylvia Cheung as Chief Financial Officer
GlobeNewswire
7/20/2020
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
GlobeNewswire
7/16/2020
Anika to Issue Second Quarter 2020 Financial Results and Business Highlights on Thursday, July 30
GlobeNewswire
7/7/2020
Lyra Therapeutics Announces Robert Richard, Ph.D., as Senior Vice President of Research and Developm...
GlobeNewswire
6/26/2020
Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors
GlobeNewswire
1/29/2020
Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Office...
Newsfile Corp
1/8/2020
Security Devices International makes management changes and security issuances
GlobeNewswire
11/21/2019
Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class ...